More Quality Measures HCPCS Code range G8694-G8970

The HCPCS codes range More Quality Measures G8694-G8970 is a standardized code set necessary for Medicare and other health insurance providers to provide healthcare claims.

Subscribe to Codify by AAPC and get the code details in a flash.

HCPCS Code Range G8694-G8970

G8694-G8970 More Quality Measures
Pneumococcal vaccine administered or previously received
Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)
Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)
Pneumococcal vaccine not administered or previously received, reason not given
Patient has documented immunity to hepatitis B and initiating anti-TNF therapy
Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician)
Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given
Sentinel lymph node biopsy procedure performed
Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change)
Showing 51 to 60 of 96 results
<< < 2 3 4 5 6 7 8 9 10 >